13th Jun 2017 18:05
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
PURETECH HEALTH PLC | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | Yes | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No | |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | No | |||
An event changing the breakdown of voting rights | No | |||
Other (please specify): | No | |||
3. Full name of person(s) subject to the notification obligation: iii |
Recordati S.p.A | |||
4. Full name of shareholder(s) (if different from 3.):iv | ||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
12 June 2017 | |||
6. Date on which issuer notified: | 13 June 2017 | |||
7. Threshold(s) that is/are crossed or reached: vi, vii |
4% | |||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type of shares
if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
GB00BY2Z0H74 | 0 | 0 | 9,554,140 | 9,554,140 | 0 | 4.02469% | 0 | |||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
9,554,140 | 4.02469% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will cease to hold: | ||
12. Date on which proxy holder will cease to hold voting rights: | ||
13. Additional information: | This transfer of voting rights relates to a merger by absorption of Recordati SA Chemical and Pharmaceutical Company into Recordati S.p.A, with Recordati S.p.A as the surviving entity. | |
14. Contact name: |
Silvia Signoretti | |
15. Contact telephone number: |
+39 02 48787533 | |
Related Shares:
PureTech